S&P 500   4,276.73 (-0.66%)
DOW   33,989.13 (-0.48%)
QQQ   330.27 (-0.60%)
AAPL   175.68 (+1.53%)
MSFT   292.49 (-0.08%)
META   176.49 (-1.66%)
GOOGL   120.55 (-0.94%)
AMZN   142.87 (-1.32%)
TSLA   924.54 (+0.53%)
NVDA   184.90 (-2.06%)
NIO   20.40 (-2.44%)
BABA   90.63 (-2.18%)
AMD   98.83 (-1.37%)
MU   61.88 (-3.10%)
T   18.52 (-0.27%)
CGC   4.11 (+8.73%)
F   16.15 (-1.70%)
GE   79.96 (-1.37%)
DIS   123.73 (-0.98%)
AMC   22.72 (-8.42%)
PYPL   100.23 (-1.81%)
PFE   49.45 (-0.82%)
NFLX   242.78 (-1.18%)
S&P 500   4,276.73 (-0.66%)
DOW   33,989.13 (-0.48%)
QQQ   330.27 (-0.60%)
AAPL   175.68 (+1.53%)
MSFT   292.49 (-0.08%)
META   176.49 (-1.66%)
GOOGL   120.55 (-0.94%)
AMZN   142.87 (-1.32%)
TSLA   924.54 (+0.53%)
NVDA   184.90 (-2.06%)
NIO   20.40 (-2.44%)
BABA   90.63 (-2.18%)
AMD   98.83 (-1.37%)
MU   61.88 (-3.10%)
T   18.52 (-0.27%)
CGC   4.11 (+8.73%)
F   16.15 (-1.70%)
GE   79.96 (-1.37%)
DIS   123.73 (-0.98%)
AMC   22.72 (-8.42%)
PYPL   100.23 (-1.81%)
PFE   49.45 (-0.82%)
NFLX   242.78 (-1.18%)
S&P 500   4,276.73 (-0.66%)
DOW   33,989.13 (-0.48%)
QQQ   330.27 (-0.60%)
AAPL   175.68 (+1.53%)
MSFT   292.49 (-0.08%)
META   176.49 (-1.66%)
GOOGL   120.55 (-0.94%)
AMZN   142.87 (-1.32%)
TSLA   924.54 (+0.53%)
NVDA   184.90 (-2.06%)
NIO   20.40 (-2.44%)
BABA   90.63 (-2.18%)
AMD   98.83 (-1.37%)
MU   61.88 (-3.10%)
T   18.52 (-0.27%)
CGC   4.11 (+8.73%)
F   16.15 (-1.70%)
GE   79.96 (-1.37%)
DIS   123.73 (-0.98%)
AMC   22.72 (-8.42%)
PYPL   100.23 (-1.81%)
PFE   49.45 (-0.82%)
NFLX   242.78 (-1.18%)
S&P 500   4,276.73 (-0.66%)
DOW   33,989.13 (-0.48%)
QQQ   330.27 (-0.60%)
AAPL   175.68 (+1.53%)
MSFT   292.49 (-0.08%)
META   176.49 (-1.66%)
GOOGL   120.55 (-0.94%)
AMZN   142.87 (-1.32%)
TSLA   924.54 (+0.53%)
NVDA   184.90 (-2.06%)
NIO   20.40 (-2.44%)
BABA   90.63 (-2.18%)
AMD   98.83 (-1.37%)
MU   61.88 (-3.10%)
T   18.52 (-0.27%)
CGC   4.11 (+8.73%)
F   16.15 (-1.70%)
GE   79.96 (-1.37%)
DIS   123.73 (-0.98%)
AMC   22.72 (-8.42%)
PYPL   100.23 (-1.81%)
PFE   49.45 (-0.82%)
NFLX   242.78 (-1.18%)

Ulta Beauty Had One Beautiful Quarter 

Ulta Beauty Had One Beautiful Quarter 

Ulta Beauty Is One Mall Stock You Can Buy 

Ulta Beauty (NASDAQ: ULTA) highlights the dichotomy of mall-based retailers; either you have it or you don’t. When it comes to what the public wants, the FQ1 results prove that Ulta definitely has what the consumers want. The company’s results were so far above the consensus as to be game-changing and that is seen in the analyst's activity as well. At least 6 of the analysts covering the stock have come out with commentary since the Q1 release and all of it is good. Among the 6 are 6 price target increases and 1 rating upgrade to Buy from Hold. The commentaries have the Marketbeat.com consensus rating edging up into firm Buy territory from weak Buy and the price target up in the 12, 3, and 1-month comparisons. 

The Marketbeat.com consensus price target of $455 is about 7% above the recent price action and it is moving higher. The consensus of the 6 most recent commentaries is closer to $481 and 13.25% of upside for share prices. Based on the results, the guidance, and the analyst's activity to date we see the consensus target trending up toward the current high price target of $500 and then moving higher. And the institutions represented by the analysts? They’ve been net buyers for 12 of the last 13 quarters and own 90% of the company. 

Ulta Beauty Strength Is More Than Skin Deep 

Ulta Beauty had a great quarter bordering on an absolute blowout and the good news carries through every portion of the report. The company reported $2.34 billion in revenue for a gain of 20.6% over last year. The strength was driven by a better-than-expected comp-store figure that left the revenue more than 1000 basis points above the consensus figure. Comp-store sales are up 18% YOY on a 10% increase in tickets and a 7.3% increase in ticket average. 


The company’s revenue strength led to significant leverage and wider margins. The gross margin widened by 120 basis points, the operating margin by 290, to drive accelerated growth on the bottom line. The GAAP earnings of $6.30 are not only up $2.20 from last year but they beat the consensus by $1.82 or about 4000 basis points and there is more good news to come. 

Turning to the guidance, the company is not only expecting to see revenue strength continue into the end of the year but for margin to remain favorable and for earnings strength as well. The new guidance for revenue assumes a range with $9.35 billion at the low end compared to the consensus figure of $9.16 and for the operating margin to widen. That combination should drive GAAP EPS of $19.20 to $20.10 which compares well to the then consensus of $19.00.

The Technical Outlook: Ulta Beauty Is On Track For A New All-Time High 

Price action in Ulta Beauty surged in the wake of the Q1 results and looks ready to set a new all-time high. Not only is the price action already above an important resistance target but the indicators are bullish as well. Assuming that price action can get above the current all-time high we see it moving up to the $455 consensus price target at least. 

Ulta Beauty Had One Beautiful Quarter 

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Ulta Beauty (ULTA)
2.6411 of 5 stars
$404.71-0.6%N/A20.03Moderate Buy$460.05
Compare These Stocks  Add These Stocks to My Watchlist 

Should you invest $1,000 in Ulta Beauty right now?

Before you consider Ulta Beauty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ulta Beauty wasn't on the list.

While Ulta Beauty currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Email Newsletter

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Most Read This Week

Recent Articles

Search Headlines:

Latest PodcastESG - Profitably Invest Your Values

David McNatt discusses ESG investing and offers ways to avoid pitfalls and to understand exactly what kinds of companies you are buying.

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.